Registered Number:08034609 |
For the year ended 30 April 2024
England and Wales
Unaudited Financial Statements
For the year ended 30 April 2024
Pharmacenna Ltd
Contents Page
1 to 2
Statement of Financial Position and Notes to the Accounts
Pharmacenna Ltd
Statement of Financial Position and Notes to the Accounts
2023
2024
24,259
18,292
Creditors: amounts falling due |
(1,264)
(3,581)
17,028
20,678
Net current assets
Total assets less current liabilities |
20,678
17,028
Creditors: amounts falling due |
(11,564)
(8,013)
12,665
Net assets
5,464
12,665
5,464
Statutory Information
Pharmacenna Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration |
number 08034609. |
158 Gilson Place
Coppetts Road
London
England
N10 1BJ
The presentation currency is £ sterling. |
1. Average number of persons employed |
During the year the average number of employees was 0
1 of 2
For the year ended 30 April 2024
Pharmacenna Ltd
Statement of Financial Position and Notes to the Accounts Continued
For the year ended 30 April 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006. |
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
statements, so far as applicable to the company. |
These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
Amin Nazem Ashoora Director |
These financial statements were approved and authorised for issue by the Board on 01 January 2025 and were signed by: |
2 of 2